New partnership with INFINITT North America
Media release, Copenhagen, DK and Phillipsburg, NJ – June 9, 2022.
INFINITT North America and Brainreader Inc. announced today a wide-ranging and unique partnership to expand and deepen the use of Brainreader’s FDA cleared Neuroreader® software. Neuroreader® analyzes an MRI sequence to determine whether brain structures are abnormal and to what extent. It visualizes and quantifies 45 individual brain structures in less than ten minutes after Magnetic Resonance Imaging.
“We are very excited about the INFINITT/Brainreader partnership” said Brainreader CEO Mads Fiig. “This relationship combines forward-looking science with an extremely useful tool for clinicians. Omar Rocha, our U.S. President, has been instrumental in building this wide embrace of the INFINITT customer base.”
INFINITT North America
INFINITT north America, an award-winning developer of enterprise imaging solutions for healthcare, will utilize Neuroreader® throughout its U.S. operations, focusing on hippocampal volume, atrophies and trends as well as applying data from Brainreader’s advanced diversified normative datasets. Brainreader’s expanding AI technology brings objectivity into clinical practice, detecting abnormal brain patterns, and is a proven guide for clinical decision making.
“AI and rigorously applied clinical science have resulted in new uses for brain data as a clinical tool, promoting earlier treatments, and more accurate diagnoses”, said David Smarro, INFINITT N.A. President and CEO. “Neuroreader® speeds up the process, increases accuracy and will improve clinical outcomes.”
“INFINITT’s large North American customer base provides an opportunity for both companies to uniquely contribute” said Omar Rocha, U.S. Brainreader President, “to improving doctors’ speed, accuracy, and depth of understanding as well as providing actionable aid in diagnosis and treatment.”
NFINITT North America is the North American business unit of INFINITT Healthcare, a global company with more than 6500 installations in 55 countries. INFINITT’s enterprise imaging solutions include INFINITT Healthcare Platform (VNA), RIS, PACS, Mammography PACS, Cardiology Suite, Digital Pathology PACS, RT PACS, Dental PACS, Ophthalmology PACS, an AI Integration Platform and an Advanced Visualization software platform.
For more information, call 877-387-6960 or visit infinittna.com.
Brainreader, founded in 2011, develops advanced healthcare-grade AI based decision support software. The Neuoreader@ technology analyzes medical imaging to provide one of the most comprehensive solutions for flagging acute abnormalities across the brain, helping healthcare professionals prioritize life threatening cases and expedite patient care.
Brainreader is committed to empowering clinicians to make a genuine difference in their patients’ lives by providing them with the best possible tools to guide clinical decision-making.
Connect with Brainreader and INFINITT North America on
Brainreader Media contact:
Global Marketing Manager